Keurig Dr Pepper Stands Firm on 2025 Projections
Keurig Dr Pepper Inc. is reaffirming its steadfast commitment to achieving mid-single-digit constant currency net sales growth and high-single-digit adjusted earnings per share growth in 2025. This unwavering stance underscores the company’s confidence in its strategic direction and operational momentum.
The market has taken notice of Keurig Dr Pepper’s resilience, with UBS issuing a Buy rating on the stock. This endorsement is a testament to the company’s ability to drive growth and create value for shareholders. Conversely, Jim Cramer has expressed reservations about the stock, citing concerns that may be worth exploring.
As the company prepares to report its second-quarter 2025 results and host a conference call on July 24, investors will be keenly watching for an update on Keurig Dr Pepper’s performance. The call will provide a critical opportunity for the company to address any lingering concerns and reaffirm its commitment to delivering on 2025 guidance.
Key Takeaways:
- Keurig Dr Pepper reaffirms 2025 guidance for mid-single-digit constant currency net sales growth and high-single-digit adjusted earnings per share growth
- UBS issues Buy rating on the stock, citing strong momentum
- Jim Cramer expresses skepticism about the stock, highlighting potential concerns
- Second-quarter 2025 results and conference call scheduled for July 24